Showing results (1-10 of 941) with videos related to
Sort By:
Pageof 95
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for diabetic nephropathySimona Bruno, Dario Cattaneo, Norberto Perico, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2004
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapyDario Cattaneo, Norberto Perico, Giuseppe RemuzziJournal of the American Society of Nephrology : JASN|June 14, 2008
The aggravating mechanisms of aldosterone on kidney fibrosisGiuseppe Remuzzi, Dario Cattaneo, Norberto PericoTransplant International : Official Journal of the European Society for Organ Transplantation|March 19, 2005
Generic cyclosporine formulations: more open questions than answersDario Cattaneo, Norberto Perico, Giuseppe RemuzziTherapeutic Advances in Cardiovascular Disease|January 28, 2009
Aldosterone and progression of kidney diseaseMonica Cortinovis, Norberto Perico, Dario Cattaneo, et al.Expert Opinion on Investigational Drugs|September 24, 2008
Investigational drugs for diabetic nephropathyMonica Cortinovis, Dario Cattaneo, Norberto Perico, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Hepatitis C infection and chronic renal diseasesNorberto Perico, Dario Cattaneo, Boris Bikbov, et al.Lancet (London, England)|November 16, 2004
Delayed graft function in kidney transplantationNorberto Perico, Dario Cattaneo, Mohamed H Sayegh, et al.Kidney International|August 8, 2002
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantationDario Cattaneo, Norberto Perico, Flavio Gaspari, et al.Personalized Medicine|May 26, 2018
Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapyDario Cattaneo, Anna Tankiewicz, Simona Merlini, et al.Pageof 95